Eric G. Devine, PhD
Assistant Professor
Boston University School of Medicine
Dept of Psychiatry
General Psychiatry

PhD, Bowling Green State University
MA, Bowling Green State University

Expertise includes: Treatment research; Clinical trials, State-of-art psychotherapy for addiction; Treatment development and training.

Active Staff Hospital Privileges
Boston Medical Center

Mood Management Versus Mood Tolerance in Alcohol Treatment
04/01/2000 - 03/31/2004 (Co-PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
5 R03 AA12210 02

R21 - Lacosamide effects on alcohol self administration and craving in heavy drinkers
09/20/2017 - 08/31/2019 (PI)

NCIG-7 Randomized, Double Blind, Placebo-Controlled Trial of the Efficacy of Intranasal Oxytocin…
01/01/2018 - 06/30/2019 (PI)
Fast Track Drugs and Biologics NIH-NIAAA

Lorcaserin - Phase 2, Multi-Center Trial of Lorcaserin for the Treatment of Cocaine Use Disorder
04/01/2017 - 12/31/2018 (PI)

FPF Professional Subject Study
01/01/2017 - 12/31/2018 (PI)

NCIG-006, Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of …
04/01/2015 - 09/19/2017 (PI)
Fast Track Drugs and Biologics NIH-NIAAA

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Devine EG, Ryan ML, Falk DE, Fertig JB, Litten RZ. An exploratory evaluation of Take Control: A novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorder. Contemp Clin Trials. 2016 Sep; 50:178-85. PMID: 27521807; DOI: 10.1016/j.cct.2016.08.006;.
  2. Knapp CM, Ciraulo DA, Sarid-Segal O, Richardson MA, Devine E, Streeter CC, Oscar-Berman M, Surprise C, Colaneri L, Putnam M, Waters M, Richambault C. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders. J Clin Psychopharmacol. 2015 Feb; 35(1):34-42.View Related Profiles. PMID: 25427171; PMCID: PMC4276485; DOI: 10.1097/JCP.0000000000000246;.
  3. Devine EG, Knapp CM, Sarid-Segal O, O'Keefe SM, Wardell C, Baskett M, Pecchia A, Ferrell K, Ciraulo DA. Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information. Contemp Clin Trials. 2015 Mar; 41:55-61.View Related Profiles. PMID: 25530307; DOI: 10.1016/j.cct.2014.12.004;.
  4. Devine, E. G., Knapp CM, Sarid-Segal, O, O’Keefe SO, Wardell C, Baskett M, Pecchia A, Ferrell, K, & Ciraulo, DA . Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information. Contemporary Clinical Trials. 2014; (41):55-61.
  5. DeMartini KS, Devine EG, DiClemente CC, Martin DJ, Ray LA, O'Malley SS. Predictors of pretreatment commitment to abstinence: results from the COMBINE study. J Stud Alcohol Drugs. 2014 May; 75(3):438-46. PMID: 24766756; PMCID: PMC4002857.
  6. Ciraulo DA, Barlow DH, Gulliver SB, Farchione T, Morissette SB, Kamholz BW, Eisenmenger K, Brown B, Devine E, Brown TA, Knapp CM. The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders. Behav Res Ther. 2013 Nov; 51(11):729-35.View Related Profiles. PMID: 24055681; PMCID: PMC3981550; DOI: 10.1016/j.brat.2013.08.003;.
  7. Devine EG, Waters ME, Putnam M, Surprise C, O'Malley K, Richambault C, Fishman RL, Knapp CM, Patterson EH, Sarid-Segal O, Streeter C, Colanari L, Ciraulo DA. Concealment and fabrication by experienced research subjects. Clin Trials. 2013; 10(6):935-48.View Related Profiles. PMID: 23867223; DOI: 10.1177/1740774513492917;.
  8. Fertig JB, Ryan ML, Falk DE, Litten RZ, Mattson ME, Ransom J, Rickman WJ, Scott C, Ciraulo D, Green AI, Tiouririne NA, Johnson B, Pettinati H, Strain EC, Devine E, Brunette MF, Kampman K, A Tompkins D, Stout R. A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients. Alcohol Clin Exp Res. 2012 Aug; 36(8):1421-30.View Related Profiles. PMID: 22324516; PMCID: PMC3355217; DOI: 10.1111/j.1530-0277.2011.01716.x;.
  9. Afshar M, Knapp CM, Sarid-Segal O, Devine E, Colaneri LS, Tozier L, Waters ME, Putnam MA, Ciraulo DA. The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression. Am J Drug Alcohol Abuse. 2012 Mar; 38(2):181-6.View Related Profiles. PMID: 22221171; DOI: 10.3109/00952990.2011.644002;.
  10. Knapp CM, Sarid-Segal O, Richardson MA, Colaneri LS, Afshar M, Devine E, Streeter CC, Piechniczek-Buczek J, Ciraulo DA. Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence. Am J Drug Alcohol Abuse. 2010 Mar; 36(2):102-5.View Related Profiles. PMID: 20337506; DOI: 10.3109/00952991003674812;.
Showing 10 of 16 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 16 publications over 10 distinct years, with a maximum of 3 publications in 2014

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

cognitive behavioral therapy
motivational interviewing
treatment research
Contact for Mentoring:

720 Harrison Ave
Boston MA 02118
Google Map

Devine's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department